EGFR, epidermal growth factor receptor, 1956

N. diseases: 1394; N. variants: 183
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 Biomarker disease BEFREE ErbB receptor phosphorylation was similarly examined in cultured schwannoma cells, normal Schwann cells, and VS tumor tissues using Western blotting. 22222570 2012
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 AlteredExpression disease BEFREE Western blots and immunofluorescence showed expression of EGFR, EpoR and FGF in HEI-193, an immortalized cell line derived from human NF2-related VS. Matrigel invasion assays were used to study the effect of Epo, FGF and bFGF on invasive behavior in HEI-193. 21178801 2011
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 AlteredExpression disease BEFREE Our findings with immunohistochemistry and western blot analysis indicate a level of ErbB-1 similar to normal peripheral nerve, but a high expression of ErbB-2 similar to the vestibular schwannoma and glioblastoma multiforme. 20547458 2010
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 Biomarker disease LHGDN Activated epidermal growth factor receptor B (ErbB) 2 and ErbB3 are abundantly expressed in VS. ErbB2 signaling is essential for Schwann cell differentiation, survival, and proliferation. 18199957 2008
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 AlteredExpression disease LHGDN These findings implicate a functional role of ErbB-2 in the benign nature of VS and that a rationale for using ErbB targeted therapies in VS may be warranted. 17964790 2007
CUI: C0027859
Disease: Acoustic Neuroma
Acoustic Neuroma
0.060 Biomarker disease BEFREE These data suggest an autocrine pathway of VS growth stimulation involving NRG and ErbB receptors. 16432850 2006